COST ANALYSIS OF RALTEGRAVIR VERSUS ATAZANAVIR/R OR DARUNAVIR/R FOR TREATMENT-NAIVE ADULTS WITH HIV-1 INFECTION IN THE UNITED STATES
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1207
https://www.valueinhealthjournal.com/article/S1098-3015(16)01275-4/fulltext
Title :
COST ANALYSIS OF RALTEGRAVIR VERSUS ATAZANAVIR/R OR DARUNAVIR/R FOR TREATMENT-NAIVE ADULTS WITH HIV-1 INFECTION IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01275-4&doi=10.1016/j.jval.2016.03.1207
First page :
A214
Section Title :
Infection - Cost Studies
Open access? :
No
Section Order :
706